Ayon, Salve S.
HRN: 21-40-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2023
LEVOFLOXACIN 500MG (TAB)
06/30/2023
07/07/2023
PO
500m
OD
Pancreatic Complex Cyst; Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes